Core Laboratories (CLB) Tops Q2 EPS by 5c, Offers Q3 & Q4 Guidance

Core Laboratories (NYSE: CLB) reported Q2 EPS of $0.82, $0.05 better than the analyst estimate of $0.77. Revenue for the quarter came in at $204 million versus the consensus estimate of $194.39 million.

Core Laboratories sees Q3 2015 EPS of $0.82-$0.84, versus the consensus of $0.80. Core Laboratories sees Q3 2015 revenue of $203-205 million, versus the consensus of $195 million.

Core Laboratories sees Q4 2015 EPS of $0.84-$0.86, versus the consensus of $0.85. Core Laboratories sees Q4 2015 revenue of $205-210 million, versus the consensus of $200 million.

For earnings history and earnings-related data on Core Laboratories (CLB) click here.

You May Also Be Interested In

• Westinghouse said to seek over $50 billion valuation in planned IPO
• Is the S&P 500 in an "earnings bubble"? Goldman weighs in
• UBS cuts KOSPI target by nearly 10% to reflect higher rates